Clinical Research Directory
Browse clinical research sites, groups, and studies.
Spinal Cord Stimulation for Refractory Pain in Erythromelalgia
Sponsor: St. Olavs Hospital
Summary
Erythromelalgia is a rare disorder characterized by red, warm, and painful extremities, which is often precipitated by warm conditions. The pathophysiology is incompletely understood. The management of pain in erythromelalgia is challenging as no single therapy has been found to be effective. Response to pharmacotherapy varies, meaning that the physician has to take a stepwise trial and error approach with each patient. Consequently, this disorder is often associated with poorer health-related quality of life. There is currently no consensus or guideline on management of pain in erythromelalgia. Spinal cord stimulation is a widely applied therapy to treat severe chronic pain of various origin. Case reports and anecdotal evidence suggest that this therapy might alleviate refractory pain in patients with erythromelalgia. The aim of this trial is to evaluate the efficacy of spinal cord stimulation for refractory pain in erythromelalgia.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2019-08-26
Completion Date
2026-01
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
Burst Spinal Cord Stimulation
Burst stimulation utilizes complex programming to deliver high-frequency stimuli of a 40 Hz burst mode with 5 spikes at 500 Hz per spike delivered in a constant current mode
Sham spinal cord stimulation
A pulse generator is implanted, but no spinal cord stimulation is provided
Locations (4)
Halden Dermatology Center
Halden, Norway
Aleris
Strømmen, Norway
Universitetssykehuset nord-norge hf
Tromsø, Norway
St Olavs Hospital
Trondheim, Norway